NO180233C - Derivater av 3-aminopyridaziner som virker på sentralnervesystemet, samt farmasöytiske preparater som inneholder dem - Google Patents

Derivater av 3-aminopyridaziner som virker på sentralnervesystemet, samt farmasöytiske preparater som inneholder dem

Info

Publication number
NO180233C
NO180233C NO921949A NO921949A NO180233C NO 180233 C NO180233 C NO 180233C NO 921949 A NO921949 A NO 921949A NO 921949 A NO921949 A NO 921949A NO 180233 C NO180233 C NO 180233C
Authority
NO
Norway
Prior art keywords
image
well
nervous system
central nervous
aminopyridazines
Prior art date
Application number
NO921949A
Other languages
English (en)
Norwegian (no)
Other versions
NO180233B (no
NO921949D0 (no
NO921949L (no
Inventor
Jean-Jacques Bourguignon
Jean-Paul Kan
Camille Georges Wermuth
Original Assignee
Sanofi Elf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Elf filed Critical Sanofi Elf
Publication of NO921949D0 publication Critical patent/NO921949D0/no
Publication of NO921949L publication Critical patent/NO921949L/no
Publication of NO180233B publication Critical patent/NO180233B/no
Publication of NO180233C publication Critical patent/NO180233C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO921949A 1991-05-16 1992-05-15 Derivater av 3-aminopyridaziner som virker på sentralnervesystemet, samt farmasöytiske preparater som inneholder dem NO180233C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9105973A FR2676444B1 (fr) 1991-05-16 1991-05-16 Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.

Publications (4)

Publication Number Publication Date
NO921949D0 NO921949D0 (no) 1992-05-15
NO921949L NO921949L (no) 1992-11-17
NO180233B NO180233B (no) 1996-12-02
NO180233C true NO180233C (no) 1997-03-12

Family

ID=9412856

Family Applications (1)

Application Number Title Priority Date Filing Date
NO921949A NO180233C (no) 1991-05-16 1992-05-15 Derivater av 3-aminopyridaziner som virker på sentralnervesystemet, samt farmasöytiske preparater som inneholder dem

Country Status (23)

Country Link
US (1) US5276036A (cs)
EP (1) EP0514277B1 (cs)
JP (1) JPH0673021A (cs)
KR (1) KR920021517A (cs)
AT (1) ATE115569T1 (cs)
AU (1) AU656770B2 (cs)
BR (1) BR9201854A (cs)
CA (1) CA2068770A1 (cs)
CZ (1) CZ282531B6 (cs)
DE (1) DE69200895T2 (cs)
DK (1) DK0514277T3 (cs)
ES (1) ES2065755T3 (cs)
FI (1) FI922235A7 (cs)
FR (1) FR2676444B1 (cs)
GR (1) GR3015389T3 (cs)
HU (2) HUT61305A (cs)
IE (1) IE66926B1 (cs)
IL (1) IL101885A (cs)
MX (1) MX9202282A (cs)
NO (1) NO180233C (cs)
NZ (1) NZ242760A (cs)
RU (1) RU2088577C1 (cs)
TW (1) TW227997B (cs)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631255A (en) * 1989-02-07 1997-05-20 Sanofi Pyridazine derivatives
US5461053A (en) * 1989-02-07 1995-10-24 Sanofi Pyridazine derivatives
JP2983141B2 (ja) * 1993-10-06 1999-11-29 株式会社三和化学研究所 新規化合物及び該化合物を有効成分とする脳機能改善剤
GB9707693D0 (en) * 1997-04-16 1997-06-04 Smithkline Beecham Plc Novel method of treatment
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
IL152531A0 (en) * 2000-05-26 2003-05-29 Pfizer Tropane derivatives useful in therapy
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
US8265724B2 (en) * 2007-03-09 2012-09-11 Nellcor Puritan Bennett Llc Cancellation of light shunting
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
US9133123B2 (en) 2010-04-23 2015-09-15 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
RU2020105929A (ru) * 2017-08-04 2021-09-06 Скайхоук Терапьютикс, Инк. Способы и композиции для модулирования сплайсинга
IL276411B2 (en) * 2018-02-02 2024-04-01 Univ Vanderbilt M4 muscarinic acetylcholine receptor antagonists
CN114126613A (zh) * 2019-02-05 2022-03-01 斯基霍克疗法公司 用于调节剪接的方法和组合物
EP3920920A4 (en) * 2019-02-05 2022-09-28 Skyhawk Therapeutics, Inc. METHODS AND COMPOSITIONS FOR MODULATING SPLICE
CN114007613A (zh) 2019-02-05 2022-02-01 斯基霍克疗法公司 用于调节剪接的方法和组合物
JP2022519311A (ja) * 2019-02-05 2022-03-22 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物
CN113661162A (zh) * 2019-02-06 2021-11-16 斯基霍克疗法公司 用于调节剪接的方法和组合物
KR20210135507A (ko) 2019-02-06 2021-11-15 스카이호크 테라퓨틱스, 인코포레이티드 스플라이싱을 조절하는 방법 및 조성물
UY38687A (es) 2019-05-17 2023-05-15 Novartis Ag Inhibidores del inflamasoma nlrp3, composiciones, combinaciones de los mismos y métodos para su uso
US11129829B2 (en) 2019-06-17 2021-09-28 Skyhawk Therapeutics, Inc. Methods for modulating splicing
WO2022166890A1 (zh) * 2021-02-08 2022-08-11 南京明德新药研发有限公司 取代的哒嗪苯酚类衍生物
UY40374A (es) 2022-08-03 2024-02-15 Novartis Ag Inhibidores de inflamasoma nlrp3

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510998B1 (fr) * 1981-08-07 1986-01-10 Sanofi Sa Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent
FR2539741A1 (fr) * 1983-01-21 1984-07-27 Sanofi Sa Composes a noyau heterocyclique diazote, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
FR2642648B1 (fr) * 1989-02-07 1991-06-21 Sanofi Sa Utilisation de derives d'alkyl-5 pyridazine comme medicaments actifs sur le systeme cholinergique
FR2665442B1 (fr) * 1990-07-31 1992-12-04 Sanofi Sa Derives d'alkyl-6 pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
FR2663326B2 (fr) * 1989-11-17 1992-10-16 Sanofi Sa Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
PT93060B (pt) * 1989-02-07 1995-12-29 Sanofi Sa Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem
GB8911158D0 (en) * 1989-05-16 1989-07-05 Janssen Pharmaceutica Nv Antiviral pyridazinamines

Also Published As

Publication number Publication date
IE66926B1 (en) 1996-02-07
IL101885A0 (en) 1992-12-30
IE921557A1 (en) 1992-11-18
KR920021517A (ko) 1992-12-18
CA2068770A1 (en) 1992-11-17
DE69200895T2 (de) 1995-06-29
ATE115569T1 (de) 1994-12-15
CZ147392A3 (en) 1993-03-17
FI922235L (fi) 1992-11-17
BR9201854A (pt) 1993-01-05
AU656770B2 (en) 1995-02-16
NZ242760A (en) 1994-12-22
FR2676444B1 (fr) 1995-03-10
DK0514277T3 (da) 1995-05-01
FI922235A7 (fi) 1992-11-17
TW227997B (cs) 1994-08-11
DE69200895D1 (de) 1995-01-26
HU211920A9 (en) 1996-01-29
US5276036A (en) 1994-01-04
ES2065755T3 (es) 1995-02-16
AU1627492A (en) 1992-11-19
HUT61305A (en) 1992-12-28
EP0514277B1 (fr) 1994-12-14
NO180233B (no) 1996-12-02
JPH0673021A (ja) 1994-03-15
HU9201626D0 (en) 1992-08-28
CZ282531B6 (cs) 1997-08-13
MX9202282A (es) 1992-12-01
EP0514277A1 (fr) 1992-11-19
NO921949D0 (no) 1992-05-15
GR3015389T3 (en) 1995-06-30
IL101885A (en) 1996-08-04
RU2088577C1 (ru) 1997-08-27
NO921949L (no) 1992-11-17
FR2676444A1 (fr) 1992-11-20
FI922235A0 (fi) 1992-05-15

Similar Documents

Publication Publication Date Title
NO180233C (no) Derivater av 3-aminopyridaziner som virker på sentralnervesystemet, samt farmasöytiske preparater som inneholder dem
EP1043324A4 (en) PURINE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM AS AN ACTIVE INGREDIENT
AR038433A2 (es) Derivados 2-alquil-2-desoxo de parahercuamida y marcfortina
NO933482L (no) N-sulfonyl-2-oksoindol-derivater som har affinitet for vasopressin- og/eller ocytocin-reseptorer
TR200100693T2 (tr) Azetidin türevleri, hazırlanmaları ve bunları içeren ilaçlar
ES2148149T3 (es) Composiciones quelantes que comprenden compuestos de alfa-diaminas.
CA2311742A1 (en) 6-amino-9-benzyl-8-hydroxypurine derivatives
PT97710A (pt) Processo para a preparacao de novos derivados da amino-piperidina,da amino-pirrolidina e de amino-per-hidroazepina
DK0499521T3 (da) Hidtil ukendte N-myristoyltransferaseinhibitorer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
NO942952D0 (no) 11-benzaldoksin-17 ater, fremgangsmåte for deres fremstilling samt legemiddel inneholdende slike
ES2098023T3 (es) Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen.
KR910009672A (ko) 피리다진 유도체, 이의 제조방법 및 이것을 함유하는 약학 조성물
HUP0100184A2 (hu) Szubsztituált 2-(benzil-amino)-2-fenil-acetamid-vegyületek és ezeket tartalmazó gyógyszerkészítmények
KR900006330A (ko) 피롤로[3,2-e]피라졸로[1,5-a]피리미딘 유도체 및 이를 함유하는 약제
DK0553016T3 (da) Hidtil ukendte naphtalenamider og -sulfonamider, fremgangsmåder til deres fremstilling samt farmaceutiske midler indeholdende dem
DK0488897T3 (da) Guanidinderivater, fremgangsmåde til fremstilling heraf samt farmaceutiske midler indeholdende disse
MX9203360A (es) Derivados de hexahidroazepinas y composiciones farmaceuticas que los contienen.
NO921159L (no) Tiazolidinon- og oksazolidinonderivater, fremgangsmaate til fremstilling derav, samt anvendelse av derivatene som vasodilatorer
KR920701240A (ko) 글루타티온 유도체
ES2111768T3 (es) Derivados de carboestirilo utilizados como agentes antiarritmicos.
ATE74924T1 (de) N-(vinblastinoyl-23)-derivate von 1aminomethylposphons|ure, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
NO980531D0 (no) Medikament for hemming av avhengighets og toleranse utviklet som fölge av et narkotisk smertestillende middel
DK0486385T3 (da) Imidazolderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
ES2140524T3 (es) Derivados de metotrexato.
DK0466662T3 (da) 6,7-Disubstituerede-2-aminotetraliner, der er aktive som immunmodulatorer, samt farmaceutiske præparater indeholdende sådanne forbindelser